Try our Advanced Search for more refined results
Intellectual Property
-
February 23, 2026
Bayer Sues J&J Over Alleged False Cancer Drug Claims
Johnson & Johnson is leaning on a flawed study to advertise its prostate cancer drug as having lower risk of death compared with Bayer's medication, alleged a New York federal lawsuit filed Monday by Bayer, which seeks to immediately halt J&J's advertising campaign and recover damages.
-
February 23, 2026
Fed. Circ. Ruling Kills Google Bid To Undo Loss, Judge Told
Touchstream Technologies Inc. has told a Texas federal judge that a Federal Circuit ruling in a different case "rebuts every argument" that Google has made to try to undo a $338.7 million jury verdict that found its Chromecast devices infringed Touchstream's patents.
-
February 23, 2026
Brie, Franco Can't Duck Claims That 'Together' Is a 'Rip-Off'
A California federal judge has refused to dismiss StudioFest's lawsuit alleging the horror film "Together," starring real-life spouses Alison Brie and Dave Franco, is a "blatant rip-off" of a screenplay the production company pitched to the couple's agents in 2020, saying the complaint plausibly alleges "substantial similarities" between the two works.
-
February 23, 2026
Synthego Urges Justices To Reject AI Bait In CRISPR Case
Synthego Corp. has called for the U.S. Supreme Court to turn away Agilent Technologies Inc.'s appeal of its invalidated CRISPR patents, saying the patent owner is inappropriately leveraging artificial intelligence to make the case sound more pressing than it is.
-
February 23, 2026
CBP Clears Redesigned Tourniquet Imports After IP Ban
U.S. Customs and Border Protection has found that a modified version of a tourniquet made by a Chinese company isn't subject to an import ban issued by the U.S. International Trade Commission after finding that earlier imports infringed a patent.
-
February 23, 2026
Pet Toy Maker Settles TM Dispute With Founder To Avoid Trial
The dog toy manufacturer Kong Co. reached a settlement Friday with its founder and his holding companies, canceling the trademark and patent infringement trial slated to start Monday and putting an end to one of two pieces of litigation between the parties, according to a court order.
-
February 23, 2026
Tempur-Pedic Maker Hits Mattress Seller With TM Suit
The "world-famous" trademarks Tempur-Pedic and Sealy are being violated by a small mattress seller that is continuing to use the marks well beyond the end of a retail agreement, Sealy Technology LLC told a North Carolina federal court.
-
February 23, 2026
Outdoors Co. Says Investor Allowed Trademark Rights Sale
A Nevada investment company and two of its officers breached their contract with Colorado-based outdoor recreation company Exxel Outdoors LLC and allowed an unauthorized sale of Exxel's trademark rights to occur without notice, it alleged in Colorado state court.
-
February 23, 2026
Justices Want Natera's Take On CareDx's False Ad Petition
The U.S. Supreme Court on Monday asked for Natera's position on a petition from rival CareDx asking the high court to review a Third Circuit decision that erased a $45 million jury award stemming from CareDx's false advertising claims.
-
February 23, 2026
Judge Tosses Patent Case Against Timex, For Now
A Connecticut federal judge on Monday tossed a suit accusing Timex of infringing a patent covering technology used in smartwatches to access a separate electronic system, but gave the patent owner an opportunity to fix its complaint.
-
February 23, 2026
Verizon And Ericsson Cleared Of Antenna Patent Infringement
A Texas federal jury has cleared Verizon and Ericsson of allegations that their cellphone towers were infringing a patent covering antenna technology in a suit brought by a Singaporean antenna and cable manufacturer.
-
February 23, 2026
Fed. Circ. Revives Cell Modem Patent Case
The Federal Circuit on Monday reversed a Minnesota federal court's decision that two patents covering cellular modem technology were invalid, but refused to revive the patent owner's breach of contract claims.
-
February 23, 2026
Detroit Lions Move To Sack 'Motor City Muscle' TM Claims
The Detroit Lions have asked a Michigan federal judge to dismiss a trademark lawsuit accusing the NFL team of infringing the "Motor City Muscle" slogan and logo used by a Detroit-area music festival.
-
February 23, 2026
5th Circ. Says Atty Fee In Architecture IP Case Wasn't Explained
The Fifth Circuit has vacated a $500,000 attorney fee award granted to the legal team representing a realty firm that was accused of infringing copyrighted designs for a senior living facility, finding that a federal judge had not explained the calculation behind that amount.
-
February 23, 2026
Justices Won't Eye Axed Bright Data Patents From $7.5M Case
The U.S. Supreme Court on Monday refused to review a Federal Circuit decision invalidating claims in four network patents owned by Bright Data, turning aside the Israeli tech company's argument that the appeals court uses "asymmetrical" claim construction rules.
-
February 23, 2026
Justices Won't Review Peloton Win In 'Bike+' TM Fight
The U.S. Supreme Court on Monday declined to hear a fitness company's appeal of a Ninth Circuit ruling that dismissed trademark infringement claims against Peloton, letting stand a decision that found no likelihood of confusion between how each business uses the "Bike+" name.
-
February 23, 2026
High Court Lets Stand Decision Saving Comcast IP Suit
The U.S. Supreme Court on Monday declined to hear Comcast's challenge to a patent infringement suit against it by WhereverTV Inc., letting stand a Federal Circuit opinion that overturned a lower court's mid-trial opinion clearing the telecommunications giant.
-
February 20, 2026
Valve's Anti-Troll Law Win Could Open New Doors
The first jury verdict in the U.S. finding a patent owner violated state law meant to curb bad faith patent suits had unique circumstances that will be hard to repeat, but attorneys say Tuesday's decision still has them considering the little-used laws more closely.
-
February 20, 2026
Centripetal Wants Squires To Erase 2022 Patent Review Order
Centripetal Networks Inc. has asked U.S. Patent and Trademark Office Director John Squires to undo a 2022 decision instituting review of a cybersecurity patent that was part of its since-vacated multibillion-dollar judgment against Cisco Systems, saying the decision conflicts with his current policies.
-
February 20, 2026
7th Circ. Wary Of Tackling Jurisdiction In 2 'Schedule A' Suits
Facing requests to address alleged jurisdictional shortcomings against e-commerce platforms in two mass counterfeiting cases Friday, a Seventh Circuit panel signaled that such discussion seems unwarranted in one vendor's fee appeal while resolving the issue separately for an e-commerce intermediary might be inappropriate given its unclear case record.
-
February 20, 2026
Ex-Exec Must Arbitrate Claims In CoStar DQ-Embroiled Spat
A California federal judge sent most of a former Matterport executive's harassment and retaliation suit to arbitration, amid a suit that has prompted CoStar's efforts to disqualify Quinn Emanuel Urquhart & Sullivan LLP counsel in separate litigation.
-
February 20, 2026
BioNTech Says Moderna's New COVID Vax Infringes Its IP
BioNTech has launched a new patent infringement suit against Moderna, claiming that the rival's newer COVID-19 vaccine exploits BioNTech's "streamlined, domain-based" vaccine technology, according to a complaint filed in Delaware federal court.
-
February 20, 2026
Squires Sinks 2 PTAB Challenges, Including 1 He Instituted
U.S. Patent and Trademark Office Director John Squires has reversed his own decision and another made by the Patent Trial and Appeal Board to institute a pair of America Invents Act petitions, citing what he called the challengers' inconsistent claim construction.
-
February 20, 2026
Fed. Circ. Backs PTAB Invalidation Of VideoLabs Patent Claims
The Federal Circuit on Friday upheld a decision by the Patent Trial and Review Board that most of the challenged claims in a VideoLabs Collective patent for synchronizing data are invalid, finding VideoLabs had forfeited its argument by raising it for the first time before the circuit.
-
February 20, 2026
Fed. Circ. Unwinds Ineligibility Ruling For Gene Therapy IP
The Federal Circuit on Friday saved Regenxbio and the University of Pennsylvania's gene therapy patent, finding that splicing together genes from different organisms results in a molecule that is "markedly different from anything occurring in nature," rendering the therapy patent eligible.
Expert Analysis
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.
-
Fed. Circ. In Oct.: Spotlight On Wording Beyond Patent Claims
The Federal Circuit's recent decision in Barrette Outdoor Living v. Fortress Iron provides useful guidance on how patent prosecutors should avoid language that triggers specification disclaimer and prosecution disclaimer, doctrines that may be used to narrow the scope of patent infringement claims, say attorneys at Knobbe Martens.
-
Series
Preaching Makes Me A Better Lawyer
Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.
-
How Large Patent Damages Awards Actually Play Out
Most large verdicts in patent infringement cases are often overturned or reduced on appeal, implying that the Federal Circuit is serving its intended purpose of correcting outlier outcomes, and that the figures that catch headlines and dominate policy debates may misrepresent economic realities, says Bowman Heiden at Berkeley School of Law.
-
How Unchecked AI Exposes Expert Opinions To Exclusion
A growing number of cases illustrate the potential for misuse of artificial intelligence tools by experts in litigation, resulting in reports with hallucinated information or unexplainable analysis, so to embrace the efficiencies AI tools introduce without falling victim to the risks, attorneys and experts should implement a few best practices, say attorneys at Willkie Farr.
-
Series
Law School's Missed Lessons: Practicing Client-Led Litigation
New litigators can better help their corporate clients achieve their overall objectives when they move beyond simply fighting for legal victory to a client-led approach that resolves the legal dispute while balancing the company's competing out-of-court priorities, says Chelsea Ireland at Cohen Ziffer.
-
Navigating 2025's Post-Grant Proceeding Shakeups
Extensive changes to the U.S. Patent Trial and Appeal Board's post-grant proceedings this year, including the new settled expectations factor and revitalization of Fintiv factors, require petitioners and patent owners alike to be mindful when selecting patents to assert and challenge, say attorneys at Quinn Emanuel.
-
Series
The Law Firm Merger Diaries: How To Build On Cultural Fit
Law firm mergers should start with people, then move to strategy: A two-level screening that puts finding a cultural fit at the pinnacle of the process can unearth shared values that are instrumental to deciding to move forward with a combination, says Matthew Madsen at Harrison.
-
Latisse Ruling's Lessons On Avoiding Chemical Patent Pitfalls
The Federal Circuit's decision in Duke v. Sandoz, reversing a $39 million infringement claim for selling a generic Latisse product, reinforces a fundamental truth in chemical patent strategy: Broad genus claims rarely survive without clear evidence of possession of specific embodiments, says Kimberly Vines at Stites & Harbison.
-
A Redirection For AIA Proceedings Under New USPTO Director
A recent U.S. Patent and Trademark Office memorandum implementing a bifurcated process for determining whether to institute an inter partes review or post-grant review, and the new director's subsequent notice of proposed rulemaking with additional limitations on the use of IPRs, may significantly affect patent litigation strategies, say attorneys at Sterne Kessler.
-
Considerations When Invoking The Common-Interest Privilege
To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.
-
Motorola Ruling Solidifies Discretionary Authority Of USPTO
The Federal Circuit's latest ruling in In re: Motorola Solutions Inc. underscores the finality and discretionary nature of the finality of Patent Trial and Appeal Board institution decisions, and clarifies that neither interim guidance nor shifting administrative policy creates substantive rights for petitioners, say attorneys at Morgan Lewis.
-
Series
The Law Firm Merger Diaries: Making The Case To Combine
When making the decision to merge, law firm leaders must factor in strategic alignment, cultural compatibility and leadership commitment in order to build a compelling case for combining firms to achieve shared goals and long-term success, says Kevin McLaughlin at UB Greensfelder.
-
How Brand-Entertainment Collabs Are Reshaping IP Strategy
As storytelling and commerce become increasingly intertwined, brand and entertainment collaborations demand equal parts creativity and legal precision, and rightsholders that proactively align their IP, clearance and ownership strategies will be best positioned to capture opportunity while mitigating risk, says Bess Morgan at Loeb & Loeb.
-
Opinion
Despite Deputy AG Remarks, DOJ Can't Sideline DC Bar
Deputy Attorney General Todd Blanche’s recent suggestion that the D.C. Bar would be prevented from reviewing misconduct complaints about U.S. Department of Justice attorneys runs contrary to federal statutes, local rules and decades of case law, and sends the troubling message that federal prosecutors are subject to different rules, say attorneys at HWG.